Work

Multicenter Phase 2 Trial of C is/Carboplatin, nAb -Paclitaxel, and C e TUX imab ( CACTUX ) as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Year: 2018

Type: article

Study design: Clinical Trial

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2017.12.029

Authors: D. Adkins, J. Ley, O. Atiq, C. Rigden, K. Trinkaus, T.M. Wildes, P. Oppelt

Institutions: Washington University in St. Louis, University of Arkansas for Medical Sciences

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2793995593

FWCI: 1.111

Cites:

Cited by: 9

Related to: 10